Regulatory Considerations to Advance EV Therapies to Licensure

Time: 3:30 pm
day: Day Two

Details:

  • How exosome companies are applying RMAT breakthrough designation
  • Unravelling regulatory strategies towards achieving BLA
  • Outlining important regulatory considerations for accelerated clinical approvals

Speakers: